Skip to main content

Find Clinical Trials

Home
Conditions
Recurrent Inflammatory Breast Carcinoma

Clinical trial condition

Recurrent Inflammatory Breast Carcinoma

Explore clinical trials studying Recurrent Inflammatory Breast Carcinoma. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies

Refine in advanced search Browse all conditions

Recurrent Inflammatory Breast Carcinoma trial results

Active, Not Recruiting

Pembrolizumab in Treating Patients With Stage IV Metastatic or Recurrent Inflammatory Breast Cancer or Triple-Negative Breast Cancer Who Have Achieved Clinical Response or Stable Disease to Prior Chemotherapy

NCT02411656

Conditions: Breast Diseases, Breast Neoplasms, Edema, +17 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details